Open-mkt buys · 90d
$88.5K
2 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$88.5K
Insiders on file
31
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| MENZIUSO RICHARD THOMAS | Principal Accounting Officer | 2 | $0 | $0 | 2026-10-01 |
| Arbet-Engels Christophe | Chief Medical Officer | 5 | $0 | $0 | 2026-10-01 |
| WEAVER GREGORY L | Chief Financial Officer | 17 | $101.2K | $0 | 2026-10-01 |
| Richardson Linda M | Chief Commercial Officer | 8 | $0 | $0 | 2026-09-16 |
| Durso Jerome Benedict | President and CEO, Director | 9 | $258.0K | $0 | 2026-08-13 |
| Roberts M Scot | Chief Scientific Officer | 93 | $2.0K | $959.7K | 2026-07-31 |
| Lawver Teri L | Director | 3 | $0 | $0 | 2026-05-01 |
| Pisano Wayne | Director | 17 | $29.6K | $402.7K | 2026-05-01 |
| Schafer Klaus | Director | 20 | $24.0K | $100.6K | 2026-05-01 |
| Hodges Philip | Director | 16 | $0 | $143.1K | 2026-05-01 |
| Sohn Catherine A. | Director | 8 | $7.9K | $0 | 2026-05-01 |
| Jorkasky Diane | Director | 12 | $2.0K | $206.9K | 2026-05-01 |
| GILL JOHN | Director | 18 | $87.0K | $141.1K | 2026-05-01 |
| SAYARE MITCHEL | Director | 14 | $9.9K | $0 | 2026-05-01 |
| Jordt Raymond M | Chief Business Officer | 30 | $0 | $0 | 2026-01-31 |
| Garg Vipin K | President and CEO | 102 | $42.0K | $626.3K | 2026-01-31 |
| Harris Matthew Scott | Director | 59 | $42.2K | $265.8K | 2025-07-31 |
| Drutz David | Director | 33 | $74.8K | $110.5K | 2024-08-19 |
| Shutterly Andrew | Acting Chief Financial Officer | 1 | $0 | $0 | 2024-07-31 |
| Eisenstadt Richard I | Chief Financial Officer | 20 | $43.1K | $0 | 2024-01-31 |
| Brown William Michael | Chief Financial Officer | 9 | $0 | $0 | 2021-07-31 |
| VHCP Management III, LLC | 10% Owner | 8 | $11.40M | $0 | 2021-02-25 |
| VHCP Co-Investment Holdings II, LLC | 10% Owner | 1 | $11.31M | $0 | 2020-06-15 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10% Owner | 2 | $0 | $957.1K | 2020-05-15 |
| Tasker Sybil | Chief Medical Officer | 6 | $0 | $0 | 2019-06-17 |
| Novartis Bioventures Ltd | 10% Owner | 18 | $2.92M | $0 | 2018-09-12 |
| NOVARTIS AG | 10% Owner | 9 | $0 | $0 | 2018-07-11 |
| Enright William | President and CEO | 9 | $663 | $0 | 2018-05-25 |
| Truffle Capital S.A.S. | 10% Owner | 36 | $642.0K | $0 | 2018-02-15 |
| SCHAFFER DERACE L | Director | 26 | $943.0K | $0 | 2017-12-29 |
| CZEREPAK ELIZABETH | CFO and EVP Corp. Development | 2 | $0 | $0 | 2017-09-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| MENZIUSO RICHARD THOMAS | Principal Accounting Officer | A Award deriv | 2026-10-01 | 2026-10-02 | 36,234 | — | $0 | 36,234 | SEC↗ |
| MENZIUSO RICHARD THOMAS | Principal Accounting Officer | A Award deriv | 2026-10-01 | 2026-10-02 | 84,546 | — | $0 | 84,546 | SEC↗ |
| Arbet-Engels Christophe | Chief Medical Officer | M Exercise deriv | 2026-10-01 | 2026-10-05 | 37,500 | — | $0 | 112,500 | SEC↗ |
| Arbet-Engels Christophe | Chief Medical Officer | F Tax w/h | 2026-10-01 | 2026-10-05 | 12,679 | $2.76 | $35.0K | 24,821 | SEC↗ |
| Arbet-Engels Christophe | Chief Medical Officer | M Exercise | 2026-10-01 | 2026-10-05 | 37,500 | — | $0 | 37,500 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | M Exercise deriv | 2026-10-01 | 2026-10-05 | 14,475 | — | $0 | 43,425 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | F Tax w/h | 2026-10-01 | 2026-10-05 | 4,379 | $2.76 | $12.1K | 49,927 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | M Exercise | 2026-10-01 | 2026-10-05 | 14,475 | — | $0 | 54,306 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | M Exercise deriv | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | M Exercise | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | F Tax w/h | 2026-09-16 | 2026-09-17 | 6,826 | $3.24 | $22.1K | 17,174 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | M Exercise deriv | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 72,000 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | F Tax w/h | 2026-09-16 | 2026-09-17 | 6,826 | $3.24 | $22.1K | 17,174 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | M Exercise | 2026-09-16 | 2026-09-17 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Durso Jerome Benedict | President and CEO | P Buy | 2026-08-13 | 2026-08-13 | 15,000 | $2.95 | $44.3K | 62,500 | SEC↗ |
| Durso Jerome Benedict | President and CEO, Director | P Buy | 2026-08-13 | 2026-08-13 | 15,000 | $2.95 | $44.3K | 62,500 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award | 2026-07-31 | 2026-08-03 | 1,753 | $2.41 | $4.2K | 39,831 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2026-07-31 | 2026-08-03 | 875 | $2.41 | $2.1K | 113,699 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2026-07-31 | 2026-08-03 | 875 | $2.41 | $2.1K | 113,699 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award | 2026-07-31 | 2026-08-03 | 1,753 | $2.41 | $4.2K | 39,831 | SEC↗ |
| SAYARE MITCHEL | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| GILL JOHN | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Hodges Philip | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Schafer Klaus | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Jorkasky Diane | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Lawver Teri L | Director | A Award deriv | 2026-05-01 | 2026-05-01 | 48,800 | — | $0 | 48,800 | SEC↗ |
| GILL JOHN | Director | P Buy | 2026-04-06 | 2026-04-06 | 9,200 | $3.41 | $31.4K | 21,700 | SEC↗ |
| Durso Jerome Benedict | President and CEO | P Buy | 2026-04-01 | 2026-04-01 | 15,000 | $3.14 | $47.1K | 47,500 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | P Buy | 2026-04-01 | 2026-04-01 | 10,000 | $3.15 | $31.5K | 38,078 | SEC↗ |
| Durso Jerome Benedict | President and CEO | P Buy | 2026-03-06 | 2026-03-09 | 20,000 | $3.54 | $70.8K | 32,500 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | P Buy | 2026-03-06 | 2026-03-09 | 5,000 | $3.54 | $17.7K | 28,078 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2026-02-26 | 2026-02-27 | 111,000 | — | $0 | 111,000 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2026-02-26 | 2026-02-27 | 259,000 | — | $0 | 259,000 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2026-02-26 | 2026-02-27 | 95,430 | — | $0 | 95,430 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2026-02-26 | 2026-02-27 | 222,670 | — | $0 | 222,670 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2026-02-02 | 2026-02-03 | 7,775 | — | $0 | 0 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2026-02-02 | 2026-02-03 | 2,329 | $5.55 | $12.9K | 112,824 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2026-02-02 | 2026-02-03 | 7,775 | — | $0 | 115,153 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award | 2026-01-31 | 2026-02-02 | 4,571 | $3.07 | $14.0K | 70,107 | SEC↗ |
| Garg Vipin K | Director | A Award | 2026-01-31 | 2026-02-02 | 6,926 | $3.07 | $21.3K | 424,519 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2026-01-31 | 2026-02-03 | 5,567 | $3.07 | $17.1K | 107,378 | SEC↗ |
| Garg Vipin K | Director | M Exercise deriv | 2026-01-30 | 2026-02-02 | 26,775 | — | $0 | 26,775 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2026-01-30 | 2026-02-03 | 9,275 | — | $0 | 9,275 | SEC↗ |
| Garg Vipin K | Director | M Exercise | 2026-01-30 | 2026-02-02 | 26,775 | — | $0 | 429,225 | SEC↗ |
| Garg Vipin K | Director | F Tax w/h | 2026-01-30 | 2026-02-02 | 11,632 | $5.60 | $65.1K | 417,593 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2026-01-30 | 2026-02-03 | 2,859 | $5.60 | $16.0K | 101,811 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2026-01-30 | 2026-02-03 | 9,275 | — | $0 | 104,670 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2026-01-27 | 2026-01-29 | 15,850 | — | $0 | 47,550 | SEC↗ |
| Garg Vipin K | Director | M Exercise deriv | 2026-01-27 | 2026-01-29 | 41,200 | — | $0 | 123,600 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise deriv | 2026-01-27 | 2026-01-29 | 15,850 | — | $0 | 47,550 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2026-01-27 | 2026-01-29 | 15,850 | — | $0 | 100,143 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 4,748 | $6.18 | $29.3K | 95,395 | SEC↗ |
| Garg Vipin K | Director | F Tax w/h | 2026-01-27 | 2026-01-29 | 17,898 | $6.18 | $110.6K | 402,450 | SEC↗ |
| Garg Vipin K | Director | M Exercise | 2026-01-27 | 2026-01-29 | 41,200 | — | $0 | 420,348 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | F Tax w/h | 2026-01-27 | 2026-01-29 | 4,229 | $6.18 | $26.1K | 65,536 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise | 2026-01-27 | 2026-01-29 | 15,850 | — | $0 | 69,765 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2026-01-25 | 2026-01-27 | 14,600 | — | $0 | 29,200 | SEC↗ |
| Garg Vipin K | Director | M Exercise deriv | 2026-01-25 | 2026-01-27 | 42,050 | — | $0 | 84,100 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise deriv | 2026-01-25 | 2026-01-27 | 14,600 | — | $0 | 29,200 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2026-01-25 | 2026-01-27 | 4,373 | $5.50 | $24.1K | 84,293 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2026-01-25 | 2026-01-27 | 14,600 | — | $0 | 88,666 | SEC↗ |
| Garg Vipin K | Director | F Tax w/h | 2026-01-25 | 2026-01-27 | 17,984 | $5.50 | $98.9K | 379,148 | SEC↗ |
| Garg Vipin K | Director | M Exercise | 2026-01-25 | 2026-01-27 | 42,050 | — | $0 | 397,132 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | F Tax w/h | 2026-01-25 | 2026-01-27 | 3,855 | $5.50 | $21.2K | 53,915 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise | 2026-01-25 | 2026-01-27 | 14,600 | — | $0 | 57,770 | SEC↗ |
| Pisano Wayne | Director | P Buy | 2026-01-08 | 2026-01-09 | 5,000 | $4.08 | $20.4K | 13,498 | SEC↗ |
| Sohn Catherine A. | Director | P Buy | 2026-01-05 | 2026-01-05 | 500 | $4.24 | $2.1K | 1,500 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise deriv | 2026-01-01 | 2026-01-05 | 9,375 | — | $0 | 9,375 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | F Tax w/h | 2026-01-01 | 2026-01-05 | 2,475 | $3.61 | $8.9K | 43,170 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise | 2026-01-01 | 2026-01-05 | 9,375 | — | $0 | 45,645 | SEC↗ |
| Jorkasky Diane | Director | P Buy | 2025-12-29 | 2025-12-29 | 527 | $3.80 | $2.0K | 527 | SEC↗ |
| GILL JOHN | Director | P Buy | 2025-12-23 | 2025-12-23 | 12,500 | $4.10 | $51.2K | 12,500 | SEC↗ |
| Durso Jerome Benedict | Director | P Buy | 2025-12-22 | 2025-12-22 | 12,500 | $4.13 | $51.6K | 12,500 | SEC↗ |
| Durso Jerome Benedict | CEO-elect | A Award deriv | 2025-12-01 | 2025-12-01 | 633,700 | — | $0 | 633,700 | SEC↗ |
| Durso Jerome Benedict | CEO-elect | A Award deriv | 2025-12-01 | 2025-12-01 | 1,824,400 | — | $0 | 1,824,400 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | M Exercise deriv | 2025-11-11 | 2025-11-12 | 18,750 | — | $0 | 56,250 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | M Exercise | 2025-11-11 | 2025-11-12 | 18,750 | — | $0 | 28,750 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | F Tax w/h | 2025-11-11 | 2025-11-12 | 5,672 | $4.28 | $24.3K | 23,078 | SEC↗ |
| Arbet-Engels Christophe | Chief Medical Officer | A Award deriv | 2025-10-01 | 2025-10-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| Arbet-Engels Christophe | Chief Medical Officer | A Award deriv | 2025-10-01 | 2025-10-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2025-10-01 | 2025-10-03 | 166,800 | — | $0 | 166,800 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2025-10-01 | 2025-10-03 | 57,900 | — | $0 | 57,900 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Hodges Philip | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| SAYARE MITCHEL | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Schafer Klaus | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| GILL JOHN | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Jorkasky Diane | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Lawver Teri L | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Durso Jerome Benedict | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2025-09-25 | 2025-09-29 | 48,800 | — | $0 | 48,800 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | A Award deriv | 2025-09-16 | 2025-09-17 | 96,000 | — | $0 | 96,000 | SEC↗ |
| Richardson Linda M | Chief Commercial Officer | A Award deriv | 2025-09-16 | 2025-09-17 | 278,000 | — | $0 | 278,000 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2025-07-31 | 2025-08-04 | 846 | $3.14 | $2.7K | 74,066 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award | 2025-07-31 | 2025-08-04 | 2,018 | $3.14 | $6.3K | 16,087 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award | 2025-07-31 | 2025-08-04 | 1,368 | $3.14 | $4.3K | 36,270 | SEC↗ |
| Sohn Catherine A. | Director | P Buy | 2025-03-17 | 2025-03-18 | 1,000 | $5.78 | $5.8K | 1,000 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | P Buy | 2025-03-13 | 2025-03-14 | 10,000 | $5.20 | $52.0K | 10,000 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | G Gift | 2025-03-07 | 2025-03-11 | 67,787 | — | $0 | 14,069 | SEC↗ |
| Durso Jerome Benedict | Director | A Award deriv | 2025-02-24 | 2025-02-25 | 69,800 | — | $0 | 69,800 | SEC↗ |
| Lawver Teri L | Director | A Award deriv | 2025-02-24 | 2025-02-26 | 69,800 | — | $0 | 69,800 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2025-02-06 | 2025-02-07 | 18,600 | — | $0 | 18,600 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2025-02-02 | 2025-02-03 | 7,775 | — | $0 | 7,775 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2025-02-02 | 2025-02-03 | 7,775 | — | $0 | 7,775 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2025-02-02 | 2025-02-03 | 18,950 | — | $0 | 18,950 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2025-02-02 | 2025-02-03 | 7,775 | — | $0 | 75,536 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2025-02-02 | 2025-02-03 | 2,316 | $6.64 | $15.4K | 73,220 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2025-02-02 | 2025-02-03 | 7,775 | — | $0 | 84,564 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2025-02-02 | 2025-02-03 | 2,708 | $6.64 | $18.0K | 81,856 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2025-02-02 | 2025-02-03 | 18,950 | — | $0 | 363,364 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2025-02-02 | 2025-02-03 | 8,282 | $6.64 | $55.0K | 355,082 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2025-02-01 | 2025-02-03 | 6,166 | — | $0 | 0 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2025-02-01 | 2025-02-03 | 6,166 | — | $0 | 0 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2025-02-01 | 2025-02-03 | 16,545 | — | $0 | 0 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2025-02-01 | 2025-02-03 | 6,166 | — | $0 | 69,562 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2025-02-01 | 2025-02-03 | 1,801 | $6.64 | $12.0K | 67,761 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2025-02-01 | 2025-02-03 | 2,109 | $6.64 | $14.0K | 76,789 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2025-02-01 | 2025-02-03 | 6,166 | — | $0 | 78,898 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2025-02-01 | 2025-02-03 | 16,545 | — | $0 | 351,645 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2025-02-01 | 2025-02-03 | 7,231 | $6.64 | $48.0K | 344,414 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2025-01-31 | 2025-02-03 | 3,184 | $5.18 | $16.5K | 63,396 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award | 2025-01-31 | 2025-02-03 | 2,614 | $5.18 | $13.5K | 34,902 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award | 2025-01-31 | 2025-02-03 | 1,905 | $5.18 | $9.9K | 72,732 | SEC↗ |
| Garg Vipin K | President and CEO | A Award | 2025-01-31 | 2025-02-03 | 4,105 | $5.18 | $21.3K | 335,100 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2025-01-30 | 2025-02-03 | 9,275 | — | $0 | 18,550 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2025-01-30 | 2025-02-03 | 9,275 | — | $0 | 18,550 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2025-01-30 | 2025-02-03 | 26,775 | — | $0 | 53,550 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2025-01-30 | 2025-02-03 | 2,709 | $7.00 | $19.0K | 60,212 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2025-01-30 | 2025-02-03 | 9,275 | — | $0 | 62,921 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2025-01-30 | 2025-02-03 | 3,173 | $7.00 | $22.2K | 70,827 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2025-01-30 | 2025-02-03 | 9,275 | — | $0 | 74,000 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2025-01-30 | 2025-02-03 | 11,701 | $7.00 | $81.9K | 330,995 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2025-01-30 | 2025-02-03 | 26,775 | — | $0 | 342,696 | SEC↗ |
| Garg Vipin K | President and CEO | A Award deriv | 2025-01-27 | 2025-01-28 | 164,800 | — | $0 | 164,800 | SEC↗ |
| Garg Vipin K | President and CEO | A Award deriv | 2025-01-27 | 2025-01-28 | 477,500 | — | $0 | 477,500 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award deriv | 2025-01-27 | 2025-01-28 | 63,400 | — | $0 | 63,400 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award deriv | 2025-01-27 | 2025-01-28 | 183,600 | — | $0 | 183,600 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award deriv | 2025-01-27 | 2025-01-28 | 183,600 | — | $0 | 183,600 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award deriv | 2025-01-27 | 2025-01-28 | 63,400 | — | $0 | 63,400 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2025-01-27 | 2025-01-28 | 183,600 | — | $0 | 183,600 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2025-01-27 | 2025-01-28 | 63,400 | — | $0 | 63,400 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2025-01-25 | 2025-01-28 | 42,050 | — | $0 | 126,150 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2025-01-25 | 2025-01-28 | 14,600 | — | $0 | 43,800 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise deriv | 2025-01-25 | 2025-01-28 | 14,600 | — | $0 | 43,800 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2025-01-25 | 2025-01-28 | 14,600 | — | $0 | 43,800 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2025-01-25 | 2025-01-28 | 42,050 | — | $0 | 334,078 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2025-01-25 | 2025-01-28 | 18,157 | $6.98 | $126.7K | 315,921 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2025-01-25 | 2025-01-28 | 14,600 | — | $0 | 69,719 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2025-01-25 | 2025-01-28 | 4,994 | $6.98 | $34.9K | 64,725 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | F Tax w/h | 2025-01-25 | 2025-01-28 | 3,862 | $6.98 | $27.0K | 32,288 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise | 2025-01-25 | 2025-01-28 | 14,600 | — | $0 | 36,150 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2025-01-25 | 2025-01-28 | 4,264 | $6.98 | $29.8K | 53,646 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2025-01-25 | 2025-01-28 | 14,600 | — | $0 | 57,910 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise deriv | 2025-01-01 | 2025-01-03 | 9,375 | — | $0 | 18,750 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | F Tax w/h | 2025-01-01 | 2025-01-03 | 2,485 | $7.21 | $17.9K | 21,550 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise | 2025-01-01 | 2025-01-03 | 9,375 | — | $0 | 24,035 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2024-11-11 | 2024-11-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| WEAVER GREGORY L | Chief Financial Officer | A Award deriv | 2024-11-11 | 2024-11-12 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| Jorkasky Diane | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| GILL JOHN | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| Schafer Klaus | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| SAYARE MITCHEL | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| Hodges Philip | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2024-09-26 | 2024-09-30 | 34,900 | — | $0 | 34,900 | SEC↗ |
| Drutz David | Director | M Exercise deriv | 2024-08-19 | 2024-08-20 | 21,750 | — | $0 | 4,350 | SEC↗ |
| Drutz David | Director | M Exercise deriv | 2024-08-19 | 2024-08-20 | 20,000 | — | $0 | 0 | SEC↗ |
| Drutz David | Director | S Sale | 2024-08-19 | 2024-08-20 | 8,184 | $6.88 | $56.3K | 55,524 | SEC↗ |
| Drutz David | Director | M Exercise | 2024-08-19 | 2024-08-20 | 20,000 | $2.60 | $52.0K | 49,785 | SEC↗ |
| Drutz David | Director | S Sale | 2024-08-19 | 2024-08-20 | 7,827 | $6.93 | $54.2K | 41,958 | SEC↗ |
| Drutz David | Director | M Exercise | 2024-08-19 | 2024-08-20 | 21,750 | $2.50 | $54.4K | 63,708 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award | 2024-07-31 | 2024-08-01 | 1,486 | $5.41 | $8.0K | 55,119 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award | 2024-07-31 | 2024-08-01 | 917 | $5.41 | $5.0K | 14,660 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2024-07-31 | 2024-08-01 | 650 | $5.41 | $3.5K | 43,310 | SEC↗ |
| Shutterly Andrew | Acting Chief Financial Offic | A Award | 2024-07-31 | 2024-08-01 | 1,259 | $5.41 | $6.8K | 11,372 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2024-02-02 | 2024-02-05 | 18,950 | — | $0 | 37,900 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2024-02-02 | 2024-02-05 | 7,775 | — | $0 | 15,550 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2024-02-02 | 2024-02-05 | 7,775 | — | $0 | 15,550 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2024-02-02 | 2024-02-05 | 8,376 | $9.32 | $78.1K | 292,028 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2024-02-02 | 2024-02-05 | 18,950 | — | $0 | 300,404 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2024-02-02 | 2024-02-05 | 2,332 | $9.32 | $21.7K | 53,633 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2024-02-02 | 2024-02-05 | 7,775 | — | $0 | 55,965 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2024-02-02 | 2024-02-05 | 2,330 | $9.32 | $21.7K | 42,660 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2024-02-02 | 2024-02-05 | 7,775 | — | $0 | 44,990 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2024-02-01 | 2024-02-05 | 16,545 | — | $0 | 16,545 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2024-02-01 | 2024-02-05 | 6,166 | — | $0 | 6,166 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2024-02-01 | 2024-02-05 | 6,166 | — | $0 | 6,166 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2024-02-01 | 2024-02-05 | 16,545 | — | $0 | 288,767 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2024-02-01 | 2024-02-05 | 7,313 | $9.88 | $72.3K | 281,454 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2024-02-01 | 2024-02-05 | 1,801 | $9.88 | $17.8K | 48,190 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2024-02-01 | 2024-02-05 | 6,166 | — | $0 | 49,991 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2024-02-01 | 2024-02-05 | 1,801 | $9.88 | $17.8K | 37,215 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2024-02-01 | 2024-02-05 | 6,166 | — | $0 | 39,016 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award | 2024-01-31 | 2024-02-01 | 4,621 | $2.69 | $12.4K | 45,012 | SEC↗ |
| Garg Vipin K | President and CEO | A Award | 2024-01-31 | 2024-02-01 | 7,889 | $2.69 | $21.2K | 272,222 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award | 2024-01-31 | 2024-02-01 | 3,257 | $2.69 | $8.8K | 43,825 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award | 2024-01-31 | 2024-02-01 | 5,030 | $2.69 | $13.5K | 13,743 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2024-01-31 | 2024-02-01 | 5,860 | $2.69 | $15.8K | 32,850 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | M Exercise deriv | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 27,825 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2024-01-30 | 2024-02-01 | 26,775 | — | $0 | 80,325 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 27,825 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 27,825 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | M Exercise | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 42,566 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | F Tax w/h | 2024-01-30 | 2024-02-01 | 2,175 | $9.80 | $21.3K | 40,391 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2024-01-30 | 2024-02-01 | 26,775 | — | $0 | 276,030 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2024-01-30 | 2024-02-01 | 11,697 | $9.80 | $114.6K | 264,333 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2024-01-30 | 2024-02-01 | 2,709 | $9.80 | $26.5K | 40,568 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 43,277 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 29,699 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2024-01-30 | 2024-02-01 | 2,709 | $9.80 | $26.5K | 26,990 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 163,200 | — | $0 | 163,200 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 58,400 | — | $0 | 58,400 | SEC↗ |
| Garg Vipin K | President and CEO | A Award deriv | 2024-01-25 | 2024-01-29 | 470,000 | — | $0 | 470,000 | SEC↗ |
| Garg Vipin K | President and CEO | A Award deriv | 2024-01-25 | 2024-01-29 | 168,200 | — | $0 | 168,200 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 58,400 | — | $0 | 58,400 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 163,200 | — | $0 | 163,200 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 163,200 | — | $0 | 163,200 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 58,400 | — | $0 | 58,400 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 163,200 | — | $0 | 163,200 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2024-01-25 | 2024-01-29 | 58,400 | — | $0 | 58,400 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise deriv | 2024-01-01 | 2024-01-04 | 9,375 | — | $0 | 28,125 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | F Tax w/h | 2024-01-01 | 2024-01-04 | 2,503 | $11.25 | $28.2K | 8,704 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | M Exercise | 2024-01-01 | 2024-01-04 | 9,375 | — | $0 | 11,207 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | M Exercise deriv | 2023-12-29 | 2024-01-02 | 12,500 | — | $0 | 25,000 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | M Exercise | 2023-12-29 | 2024-01-02 | 12,500 | — | $0 | 36,335 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | F Tax w/h | 2023-12-29 | 2024-01-02 | 3,044 | $11.25 | $34.2K | 33,291 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Jorkasky Diane | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| SAYARE MITCHEL | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| GILL JOHN | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Hodges Philip | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Drutz David | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Schafer Klaus | Director | A Award deriv | 2023-09-28 | 2023-09-29 | 26,100 | — | $0 | 26,100 | SEC↗ |
| Drutz David | Director | P Buy | 2023-08-15 | 2023-08-15 | 300 | $2.88 | $864 | 29,785 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award | 2023-07-31 | 2023-08-02 | 1,832 | $2.81 | $5.1K | 1,832 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2023-07-31 | 2023-08-02 | 568 | $2.81 | $1.6K | 20,424 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award | 2023-07-31 | 2023-08-02 | 691 | $2.81 | $1.9K | 34,002 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award | 2023-07-31 | 2023-08-02 | 1,825 | $2.81 | $5.1K | 23,835 | SEC↗ |
| Garg Vipin K | President and CEO | A Award | 2023-07-31 | 2023-08-02 | 126 | $2.81 | $354 | 249,255 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | P Buy | 2023-03-24 | 2023-03-24 | 10,000 | $4.31 | $43.1K | 22,010 | SEC↗ |
| Sohn Catherine A. | Director | A Award deriv | 2023-03-23 | 2023-03-27 | 47,000 | — | $0 | 47,000 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | P Buy | 2023-03-23 | 2023-03-23 | 10,000 | $4.22 | $42.2K | 33,311 | SEC↗ |
| Drutz David | Director | P Buy | 2023-03-23 | 2023-03-27 | 9,000 | $4.27 | $38.4K | 29,484 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2023-02-02 | 2023-02-06 | 18,950 | — | $0 | 56,850 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2023-02-02 | 2023-02-06 | 7,775 | — | $0 | 23,325 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2023-02-02 | 2023-02-06 | 7,775 | — | $0 | 23,325 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2023-02-02 | 2023-02-06 | 18,950 | — | $0 | 257,551 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2023-02-02 | 2023-02-06 | 8,422 | $15.04 | $126.7K | 249,129 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2023-02-02 | 2023-02-06 | 2,364 | $15.04 | $35.6K | 23,311 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2023-02-02 | 2023-02-06 | 7,775 | — | $0 | 25,675 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2023-02-02 | 2023-02-06 | 7,775 | — | $0 | 22,231 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2023-02-02 | 2023-02-06 | 2,375 | $15.04 | $35.7K | 19,856 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise deriv | 2023-02-01 | 2023-02-02 | 16,546 | — | $0 | 33,090 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise deriv | 2023-02-01 | 2023-02-02 | 6,166 | — | $0 | 12,332 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise deriv | 2023-02-01 | 2023-02-02 | 6,166 | — | $0 | 12,332 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2023-02-01 | 2023-02-02 | 7,658 | $13.78 | $105.5K | 238,601 | SEC↗ |
| Garg Vipin K | President and CEO | M Exercise | 2023-02-01 | 2023-02-02 | 16,546 | — | $0 | 246,259 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | M Exercise | 2023-02-01 | 2023-02-02 | 6,166 | — | $0 | 20,083 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | F Tax w/h | 2023-02-01 | 2023-02-02 | 2,183 | $13.78 | $30.1K | 17,900 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | F Tax w/h | 2023-02-01 | 2023-02-02 | 2,183 | $13.78 | $30.1K | 14,456 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | M Exercise | 2023-02-01 | 2023-02-02 | 6,166 | — | $0 | 16,639 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award | 2023-01-31 | 2023-02-02 | 1,172 | $10.21 | $12.0K | 12,010 | SEC↗ |
| Garg Vipin K | President and CEO | A Award | 2023-01-31 | 2023-02-02 | 1,938 | $10.21 | $19.8K | 229,713 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award | 2023-01-31 | 2023-02-02 | 1,296 | $10.21 | $13.2K | 13,917 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award | 2023-01-31 | 2023-02-02 | 1,436 | $10.21 | $14.7K | 10,473 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 37,100 | — | $0 | 37,100 | SEC↗ |
| Harris Matthew Scott | Chief Medical Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 37,100 | — | $0 | 37,100 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 37,100 | — | $0 | 37,100 | SEC↗ |
| Roberts M Scot | Chief Scientific Officer | A Award deriv | 2023-01-30 | 2023-02-01 | 105,000 | — | $0 | 105,000 | SEC↗ |
| Garg Vipin K | President and CEO | A Award deriv | 2023-01-30 | 2023-02-01 | 107,100 | — | $0 | 107,100 | SEC↗ |
| Garg Vipin K | President and CEO | A Award deriv | 2023-01-30 | 2023-02-01 | 302,900 | — | $0 | 302,900 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award deriv | 2023-01-03 | 2023-01-04 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Jordt Raymond M | Chief Business Officer | A Award deriv | 2023-01-03 | 2023-01-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | M Exercise deriv | 2022-12-31 | 2023-01-03 | 12,500 | — | $0 | 37,500 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | F Tax w/h | 2022-12-31 | 2023-01-03 | 3,028 | $16.45 | $49.8K | 10,838 | SEC↗ |
| Eisenstadt Richard I | Chief Financial Officer | M Exercise | 2022-12-31 | 2023-01-03 | 12,500 | — | $0 | 13,866 | SEC↗ |
| Pisano Wayne | Director | M Exercise deriv | 2022-12-22 | 2022-12-22 | 20,000 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | S Sale | 2022-12-22 | 2022-12-22 | 20,000 | $15.01 | $300.2K | 8,498 | SEC↗ |
| Pisano Wayne | Director | M Exercise | 2022-12-22 | 2022-12-22 | 20,000 | $2.60 | $52.0K | 28,498 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2022-11-30 | 2022-12-01 | 3,007 | $9.95 | $29.9K | 227,775 | SEC↗ |
| Drutz David | Director | M Exercise deriv | 2022-11-18 | 2022-11-21 | 139 | — | $0 | 0 | SEC↗ |
| Drutz David | Director | M Exercise | 2022-11-18 | 2022-11-21 | 139 | $2.40 | $334 | 20,151 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2022-10-30 | 2022-10-31 | 3,007 | $12.77 | $38.4K | 230,782 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2022-09-30 | 2022-10-03 | 3,008 | $12.77 | $38.4K | 233,789 | SEC↗ |
| Hodges Philip | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| SAYARE MITCHEL | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| Schafer Klaus | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| GILL JOHN | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| Drutz David | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| Jorkasky Diane | Director | A Award deriv | 2022-09-29 | 2022-09-30 | 23,500 | — | $0 | 23,500 | SEC↗ |
| Garg Vipin K | President and CEO | S Sale | 2022-08-31 | 2022-09-01 | 20,000 | $20.02 | $400.4K | 236,797 | SEC↗ |
| Garg Vipin K | President and CEO | F Tax w/h | 2022-08-30 | 2022-09-01 | 3,007 | $18.94 | $57.0K | 256,797 | SEC↗ |
| GILL JOHN | Director | S Sale | 2022-08-12 | 2023-07-06 | 2,714 | $15.00 | $40.7K | 2,771 | SEC↗ |
| Garg Vipin K | President and CEO | S Sale | 2022-08-12 | 2022-08-12 | 15,000 | $15.06 | $225.9K | 259,804 | SEC↗ |